The company is outgrowing its own explanations: management keeps telling investors the reported numbers are not the busi
The model's full reasoning — Q4 2022 call → NOWe need to determine if management conveys that reported results do not represent the business currently running, i.e., the printed period is stale relative to the operating present. Look for statements indicating that the business has moved ahead of what the numbers show, with concrete actions/achievements already in place. Key points from transcript: - Chad Robins: "We're off to a great start in 2023. The momentum is building... we're managing our operating expenses... we have the capital to fuel sustainable growth." This is general. - On MRD: "We are off to a great start this year with clinical clonoSEQ orders at a record high for us in the past month." This indicates current activity ahead of reported period. - "We expect DLBCL to be a meaningful contributor in the second half of 2023." That's future. - "Epic integration which are expected in the back half of the year" – future. - On drug discovery: "We're making good progress with Genentech... we delivered two additional shared TCR data packages... completed end-to-end process runs... This year, we are focused on standardizing and optimizing..." This is ongoing work, but not yet contributing to revenue. - Tycho: "we had solid performance in 2022... we're growing revenues, managing OpEx..." – ordinary. - On guidance: first quarter will be lowest due to seasonality, launches later, etc. That's typical. Does management explicitly say the reported period doesn't reflect current business? They mention record orders in the past month, implying current run-rate higher. But is that a consistent theme? They also talk about many future drivers. The question asks: "management repeatedly or substantially indicate that the just-reported numbers describe a company that has already been left behind by what is now actually happening inside the business?" The phrase "record high for us in the past month" suggests current volume is above what Q4 showed. Also they mention sales force doubled during year, now fully trained, so productivity is higher. But is that repeated? They also talk about community penetration increasing from 12% to 15% just last quarter, but that's within the period. Check for examples: management explaining that meaningful business began late in period or just after. They launched DLBCL in December, so just at end of period. Epic integration expected back half.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| VRE | Veris Residential, Inc. | Q4 2022 | 2023-02-22 | D |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
VRE · Q4 2022 → YESThe question is: Does management convey that the reported results for the period do not represent the business the company is actually running today? That the just-reported numbers describe a company ...YES The transcript shows management repeatedly framing the reported period as transitional and not reflective of the current business: the shift to a pure-play multi-family company has already reduced office and hotel exposure while driving multi-family NOI share to 98%, with Haus25 leased at 95% ahead of schedule and same-store NOI guidance of 4-6% for 2023. They explicitly note that earnings variability stems from the ongoing asset sales and reallocation, with the business now positioned for growth as the transformation concludes, and they highlight post-period activity like additional sales and stabilized properties to underscore that the reported numbers capture a pre-transition state.
PFE · Q4 2023 → YESThe question is: Does management convey that the reported results do not represent the business the company is actually running today? That the just-reported numbers describe a company that has alread...NO The transcript shows management framing 2023 results as a challenging year with declines driven by COVID products, while positioning 2024 as a year of execution and growth through new priorities like the Seagen acquisition (closed late in 2023 with minimal contribution) and new product launches. This is a standard results-and 2024 outlook discussion, with forward-looking elements on pipeline, margins, and capital allocation rather than indicating the reported period is stale relative to current operations.
PRIM · Q2 2018 → YESThe question is whether management conveys that the reported results for Q2 2018 do not represent the business the company is actually running today. Specifically, if the printed period is stale relat...YES The transcript shows management repeatedly framing the Q2 results as a partial picture due to the late June 1 acquisition of Willbros. They note the business is "running as planned," highlight one-month revenue contribution of $1.